These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia. Paul M; Soares-Weiser K; Grozinsky S; Leibovici L Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941 [TBL] [Abstract][Full Text] [Related]
10. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia. Paul M; Soares-Weiser K; Grozinsky S; Leibovici L Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467 [TBL] [Abstract][Full Text] [Related]
11. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664 [TBL] [Abstract][Full Text] [Related]
13. Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study). Albasanz-Puig A; Gudiol C; Puerta-Alcalde P; Ayaz CM; Machado M; Herrera F; Martín-Dávila P; Laporte-Amargós J; Cardozo C; Akova M; Álvarez-Uría A; Torres D; Fortún J; García-Vidal C; Muñoz P; Bergas A; Pomares H; Mercadal S; Durà-Miralles X; García-Lerma E; Pallarès N; Carratalà J Antimicrob Agents Chemother; 2021 Jul; 65(8):e0004521. PubMed ID: 33972253 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy for gram-negative bacteremia. Calandra T; Cometta A Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770 [TBL] [Abstract][Full Text] [Related]
15. Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. Martínez JA; Cobos-Trigueros N; Soriano A; Almela M; Ortega M; Marco F; Pitart C; Sterzik H; Lopez J; Mensa J Antimicrob Agents Chemother; 2010 Sep; 54(9):3590-6. PubMed ID: 20585123 [TBL] [Abstract][Full Text] [Related]
16. Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia. Bliziotis IA; Petrosillo N; Michalopoulos A; Samonis G; Falagas ME PLoS One; 2011; 6(10):e26470. PubMed ID: 22046290 [TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Korvick JA; Bryan CS; Farber B; Beam TR; Schenfeld L; Muder RR; Weinbaum D; Lumish R; Gerding DN; Wagener MM Antimicrob Agents Chemother; 1992 Dec; 36(12):2639-44. PubMed ID: 1482131 [TBL] [Abstract][Full Text] [Related]
18. Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia. Falagas ME Antimicrob Agents Chemother; 1997 Nov; 41(11):2593-4. PubMed ID: 9371379 [No Abstract] [Full Text] [Related]
19. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis. Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215 [TBL] [Abstract][Full Text] [Related]
20. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. Falagas ME; Matthaiou DK; Bliziotis IA J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]